Search - tctmd.com

Displaying 21 - 30 of 30

Sort: Relevancy | Date

Steep Rise in PCI for Ischemic Heart Failure Seen in Sweden, but Survival Favors CABG

Shelley Wood

May 28, 2019

News Daily News

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

Shelley Wood

November 02, 2018

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Daily News

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

Caitlin E. Cox

July 30, 2018

News Industry News

BioCardia Receives New Potency Assay Patent, Providing Further Protection to Autologous Cell Therapy Programs in Heart Failure and Refractory Angina

April 25, 2018

News Daily News

Quicker Diuretics Not Associated With Better Outcomes in Acute Heart Failure

Todd Neale

March 25, 2018

News Industry News

Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure

October 27, 2015

News Daily News

CMR Can Accurately Diagnose Cause of Heart Failure

Caitlin E. Cox

September 16, 2011

News Daily News

CABG Plus Stem Cells Equals Improved LV Function in MI Patients with Heart Failure

Jason Kahn

June 06, 2011

News Conference News

STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients

Caitlin E. Cox

April 04, 2011

Advertisement

Steep Rise in PCI for Ischemic Heart Failure Seen in Sweden, but Survival Favors CABG

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

BioCardia Receives New Potency Assay Patent, Providing Further Protection to Autologous Cell Therapy Programs in Heart Failure and Refractory Angina

Quicker Diuretics Not Associated With Better Outcomes in Acute Heart Failure

Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure

CMR Can Accurately Diagnose Cause of Heart Failure

CABG Plus Stem Cells Equals Improved LV Function in MI Patients with Heart Failure

STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content